Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Not applicableUnknownNCT03490084
What this trial is testing

Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 300
Not applicableStudy completedNCT04908852
What this trial is testing

Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Dana-Farber Cancer Institute 10
Not applicableStudy completedNCT02598752
What this trial is testing

Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeHematological Malignancy+3 more
Memorial Sloan Kettering Cancer Center 11
Not applicableActive Not RecruitingNCT06323447
What this trial is testing

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Who this might be right for
Diffuse Large B Cell LymphomaMultiple Myeloma
Leuko Labs, Inc. 210
Testing effectiveness (Phase 2)Study completedNCT01253447
What this trial is testing

AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00110058
What this trial is testing

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT02047578
What this trial is testing

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

Who this might be right for
Acute Lymphoblastic Leukemia
Seoul National University Hospital 38
Not applicableActive Not RecruitingNCT06396611
What this trial is testing

Exercise As Intervention in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Universidade do Porto 11
Testing effectiveness (Phase 2)UnknownNCT01298934
What this trial is testing

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Who this might be right for
Primary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis
Ronald Hoffman 22
Testing effectiveness (Phase 2)Looking for participantsNCT07154264
What this trial is testing

DZD8586 Combination in CLL/SLL (TAI-SHAN10)

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Dizal Pharmaceuticals 66
Early research (Phase 1)Study completedNCT01588132
What this trial is testing

Anfibatide Phase 1 Clinical Trial in Healthy Volunteers

Who this might be right for
Coronary Heart DiseaseCoagulation Disorder
Lee's Pharmaceutical Limited 94
Not applicableStudy completedNCT02080884
What this trial is testing

An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Hoffmann-La Roche 150
Not applicableStudy completedNCT02158052
What this trial is testing

Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

Who this might be right for
Multiple MyelomaAmyloidosis
Massachusetts General Hospital 2
Not applicableLooking for participantsNCT03549858
What this trial is testing

Patient Reported Outcomes Burdens and Experiences - Phase 3

Who this might be right for
HemophiliaChronic Disease
McMaster University 1,000
Not applicableNo Longer AvailableNCT05269771
What this trial is testing

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT04044209
What this trial is testing

The IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Yale University
Testing effectiveness (Phase 2)Looking for participantsNCT06191263
What this trial is testing

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Ryvu Therapeutics SA 98
Not applicableStudy completedNCT01653106
What this trial is testing

Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Ohio State University Comprehensive Cancer Center 148
Next Page